SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis

Hirohito Yamaguchi1, Nicholas T Woods, Jay F Dorsey

  • 1H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

Insights

Bif-1 protein phosphorylation by c-Src kinase prevents its interaction with Bax, inhibiting apoptosis during anoikis. This reveals a novel mechanism for Src signaling in preventing cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Bif-1 protein interacts with Bax to induce apoptosis, but the precise mechanism remains unclear.
  • Understanding Bif-1-Bax interaction is crucial for deciphering cell death pathways.

Purpose of the Study:

  • To elucidate the molecular mechanism regulating the interaction between Bif-1 and Bax.
  • To investigate the role of Bif-1 phosphorylation in apoptosis and anoikis.

Main Methods:

  • Investigated Bif-1 phosphorylation status under apoptotic stimuli.
  • Identified c-Src as the kinase phosphorylating Bif-1 at tyrosine 80.
  • Assessed the impact of Src-mediated phosphorylation on Bif-1-Bax interaction and Bax activation during anoikis.

Main Results:

  • Bif-1 phosphorylation is repressed by apoptotic stimuli.
  • c-Src directly phosphorylates Bif-1 on tyrosine 80.
  • Src phosphorylation of Bif-1 inhibits its binding to Bax, suppressing Bax activation and anoikis.

Conclusions:

  • Phosphorylation of Bif-1 by c-Src impairs its interaction with Bax, thereby inhibiting apoptosis.
  • This phosphorylation-dependent mechanism provides a novel way for Src oncogenic signaling to prevent cell death.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...